What’s Up With mRNA Research? A research nurse holds an injection of a BioNTech mRNA cancer immunotherapy for non-small cell ...
We recently published a list of Did Jim Cramer Nail or Miss These 14 Stocks? In this article, we are going to take a look at ...
1don MSN
Researchers at the University of Cologne and University Hospital Cologne have determined that the novel mRNA-based COVID-19 ...
"There will not be any research funded by NIH on mRNA vaccines," the scientist in New York similarly told the outlet. "MAGA ...
Scientists say that officials from the National Institutes of Health urged them to remove references to mRNA vaccine ...
In a legal battle between BioNTech and CureVac, the European Patent Office declared a patent owned by CureVac ...
The fears over mRNA-vaccine grant cancellations come after NIH staff members were instructed to compile a list of grants for ...
As part of the Fast Track designation, Sanofi is set to launch a Phase I/II trial to evaluate the immunogenicity and safety of its novel mRNA vaccine in preventing chlamydia.
A new study by Fikrig and other researchers, published Wednesday in Science Translational Medicine, uses a powerful ...
A vaccine kept patients free of pancreatic cancer for years, yet new reports say the NIH is advising against mentioning mRNA tech in grants.
Researchers have discovered that mRNA-based COVID-19 vaccines have a persistent effect on the innate immune system. These mechanisms may help the human body to better protect itself against potential ...
The European Patent Office declared a patent owned by CureVac , valid, after a challenge from drugmaker BioNTech , the company said on Thursday.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback